Joel Sendek
CIK: 0001720875
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CATX
Perspective Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Sendek Joel
Sendek Joel (SEC CIK 0001720875) files insider reports with the SEC as Chief Financial Officer of Perspective Therapeutics, Inc. (CATX).
Signal8 holds 2 ownership filings by Sendek Joel (1 Form 3, 1 Form 4), filed on Sep 5, 2025. Those filings report 1 transaction, the latest on Sep 4, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Sendek Joel's filings is in SEATTLE, WA.
Recent filings by Sendek Joel
- Sep 4, 2025: Grant or award of CATX derivative securities (Form 4, code A).
Other insiders filing for Perspective Therapeutics, Inc. (CATX)
- Lantheus Alpha Therapy, LLC, 10% Owner
- Lantheus Holdings, Inc., 10% Owner
- Martinez Maria E, Director
- Morich Frank, Director
- Williamson Robert F III, Director
- HENSON HEIDI, Director